Miyauchi T et al. |
Effect of donor-specific splenocytes via portal vein and FK506 in rat small bowel transplantation. |
1998 |
Transplantation |
pmid:9448139
|
Rosen HR et al. |
Significance of early aminotransferase elevation after liver transplantation. |
1998 |
Transplantation |
pmid:9448146
|
Koprak S et al. |
Depletion of the mature CD4+8- thymocyte subset by FK506 analogs correlates with their immunosuppressive and calcineurin inhibitory activities. |
1996 |
Transplantation |
pmid:8623162
|
Calmus Y et al. |
Assessing renal function with daclizumab induction and delayed tacrolimus introduction in liver transplant recipients. |
2010 |
Transplantation |
pmid:20495510
|
Egli A et al. |
Inhibition of polyomavirus BK-specific T-Cell responses by immunosuppressive drugs. |
2009 |
Transplantation |
pmid:19935369
|
Selzner N et al. |
Antiviral treatment of recurrent hepatitis C after liver transplantation: predictors of response and long-term outcome. |
2009 |
Transplantation |
pmid:19935376
|
Lee D et al. |
Age and Early Graft Function Relate With Risk-Benefit Ratio of Allogenic Islet Transplantation Under Antithymocyte Globulin-Mycophenolate Mofetil-Tacrolimus Immune Suppression. |
2017 |
Transplantation |
pmid:27779572
|
Khanna A et al. |
Donor bone marrow potentiates the effect of tacrolimus on nonvascularized heart allograft survival: association with microchimerism and growth of donor dendritic cell progenitors from recipient bone marrow. |
1998 |
Transplantation |
pmid:9500620
|
Wozniak LJ et al. |
Donor-specific HLA Antibodies Are Associated With Late Allograft Dysfunction After Pediatric Liver Transplantation. |
2015 |
Transplantation |
pmid:26038872
|
Gayowski T et al. |
Orthotopic liver transplantation in high-risk patients: risk factors associated with mortality and infectious morbidity. |
1998 |
Transplantation |
pmid:9500623
|
Johnson MC et al. |
QT prolongation and Torsades de Pointes after administration of FK506. |
1992 |
Transplantation |
pmid:1373538
|
Kim YI et al. |
Stimulation of liver regeneration by pretreatment with azathioprine as well as cyclosporine and FK506. |
1992 |
Transplantation |
pmid:1373539
|
Cosio FG et al. |
Comparison of low versus high tacrolimus levels in kidney transplantation: assessment of efficacy by protocol biopsies. |
2007 |
Transplantation |
pmid:17318073
|
Budde K et al. |
Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in maintenance renal transplant recipients receiving tacrolimus: clinical, pharmacokinetic, and pharmacodynamic outcomes. |
2007 |
Transplantation |
pmid:17318074
|
Bierer BE et al. |
Mechanisms of immunosuppression by FK506. Preservation of T cell transmembrane signal transduction. |
1990 |
Transplantation |
pmid:1694317
|
Eiras G et al. |
Species differences in sensitivity of T lymphocytes to immunosuppressive effects of FK 506. |
1990 |
Transplantation |
pmid:1694318
|
Jain A et al. |
Pharmacokinetics of tacrolimus in living donor liver transplant and deceased donor liver transplant recipients. |
2008 |
Transplantation |
pmid:18347534
|
Ciancio G et al. |
Daclizumab induction, tacrolimus, mycophenolate mofetil and steroids as an immunosuppression regimen for primary kidney transplant recipients. |
2002 |
Transplantation |
pmid:11965039
|
Khanna A et al. |
Tacrolimus induces increased expression of transforming growth factor-beta1 in mammalian lymphoid as well as nonlymphoid cells. |
1999 |
Transplantation |
pmid:10071036
|
Kessler M et al. |
A renal allograft recipient with late recurrence of focal and segmental glomerulosclerosis after switching from cyclosporine to tacrolimus. |
1999 |
Transplantation |
pmid:10071045
|
Mor E et al. |
Late-onset acute rejection in orthotopic liver transplantation--associated risk factors and outcome. |
1992 |
Transplantation |
pmid:1279849
|
Hirano Y et al. |
The effects of FK506 and cyclosporine on the exocrine function of the rat pancreas. |
1992 |
Transplantation |
pmid:1279850
|
van Rijen MM et al. |
CD154 is expressed during treatment with calcineurin inhibitors after organ transplantation. |
2002 |
Transplantation |
pmid:12042657
|
Horner BM et al. |
Recipient damage after musculocutaneous transplant rejection. |
2008 |
Transplantation |
pmid:18946349
|
Textor SC et al. |
Systemic and renal hemodynamic differences between FK506 and cyclosporine in liver transplant recipients. |
1993 |
Transplantation |
pmid:7685934
|
di Francesco F et al. |
One year follow-up of steroid-free immunosuppression plus everolimus in isolated pancreas transplantation. |
2008 |
Transplantation |
pmid:18946356
|
Bäckman L et al. |
FK506 trough levels in whole blood and plasma in liver transplant recipients. Correlation with clinical events and side effects. |
1994 |
Transplantation |
pmid:7509516
|
Higgins RM et al. |
Acute rejection after renal transplantation is reduced by approximately 50% by prior therapeutic blood transfusions, even in tacrolimus-treated patients. |
2004 |
Transplantation |
pmid:14966430
|
Mahé E et al. |
Drug-induced hypersensitivity syndrome associated with primary Epstein-Barr virus and human herpesvirus 6 infections in a child intestinal transplant recipient. |
2004 |
Transplantation |
pmid:14966435
|
Boillot O et al. |
Reversal of early acute rejection with increased doses of tacrolimus in liver transplantation: a pilot study. |
1998 |
Transplantation |
pmid:9825815
|
Tanaka M et al. |
Effect of anticomplement agent K76 COOH on hamster-to-rat and guinea pig-to-rat heart xenotransplantation. |
1996 |
Transplantation |
pmid:8830837
|
Opelz G |
Comparison of FK506 and cyclosporine. |
1996 |
Transplantation |
pmid:8830844
|
Abadja F et al. |
Impact of mycophenolic acid and tacrolimus on Th17-related immune response. |
2011 |
Transplantation |
pmid:21818055
|
Jain AB et al. |
A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone, and mycophenolate mofetil in primary adult liver transplant recipients: an interim report. |
1998 |
Transplantation |
pmid:9846530
|
Watson MJ et al. |
Renal function impacts outcomes after intestinal transplantation. |
2008 |
Transplantation |
pmid:18622288
|
Mourad M et al. |
Sirolimus and tacrolimus trough concentrations and dose requirements after kidney transplantation in relation to CYP3A5 and MDR1 polymorphisms and steroids. |
2005 |
Transplantation |
pmid:16249748
|
Hariharan S |
Case 2: strategies to minimize the use of calcineurin inhibitors (CNIs). |
2002 |
Transplantation |
pmid:12357988
|
Vyas S et al. |
Outcome of twin pregnancy in a renal transplant recipient treated with tacrolimus. |
1999 |
Transplantation |
pmid:10030303
|
Vafadari R et al. |
Inhibitory effect of tacrolimus on p38 mitogen-activated protein kinase signaling in kidney transplant recipients measured by whole-blood phosphospecific flow cytometry. |
2012 |
Transplantation |
pmid:22643331
|
Schena FP et al. |
Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial. |
2009 |
Transplantation |
pmid:19155978
|
Morales JM et al. |
Improved renal function, with similar proteinuria, after two years of early tacrolimus withdrawal from a regimen of sirolimus plus tacrolimus. |
2008 |
Transplantation |
pmid:18724234
|
Muraki T et al. |
Antithrombotic effect of FK506 versus prothrombotic effect of cyclosporine in vivo. |
1995 |
Transplantation |
pmid:7544038
|
Fridell JA et al. |
Causes of mortality beyond 1 year after primary pediatric liver transplant under tacrolimus. |
2002 |
Transplantation |
pmid:12499888
|
Aw MM et al. |
Basiliximab (Simulect) for the treatment of steroid-resistant rejection in pediatric liver transpland recipients: a preliminary experience. |
2003 |
Transplantation |
pmid:12660504
|
Hebert MF et al. |
Interpreting tacrolimus concentrations during pregnancy and postpartum. |
2013 |
Transplantation |
pmid:23274970
|
Thai NL et al. |
Pancreas transplantation under alemtuzumab (Campath-1H) and tacrolimus: Correlation between low T-cell responses and infection. |
2006 |
Transplantation |
pmid:17198253
|
Ueki S et al. |
Control of allograft rejection by applying a novel nuclear factor-kappaB inhibitor, dehydroxymethylepoxyquinomicin. |
2006 |
Transplantation |
pmid:17198266
|
Uchikoshi F et al. |
Restoration of immune abnormalities in diabetic BB rats after pancreas transplantation. I. Macrochimerism of donor-graft-derived RT6+ T cells responsible for restoration of immune responsiveness and suppression of autoimmune reaction. |
1996 |
Transplantation |
pmid:8669109
|
Macphee IA et al. |
Tacrolimus pharmacogenetics: the CYP3A5*1 allele predicts low dose-normalized tacrolimus blood concentrations in whites and South Asians. |
2005 |
Transplantation |
pmid:15729180
|
Baggio B et al. |
Relationship between plasma phospholipid polyunsaturated fatty acid composition and bone disease in renal transplantation. |
2005 |
Transplantation |
pmid:16314806
|